Literature DB >> 26884961

Prostaglandin-endoperoxide synthase 2 (PTGS2) rs20417 polymorphism and prostate cancer risk: a meta analysis.

Lei Zhang1, Yan Zhang2, Xu Zhang1, Baofa Hong1.   

Abstract

BACKGROUND: Genetic variation of SNPs in the PTGS2 gene is reported to be capable of creating tissue milieu favoring tumorigenesis. Some studies have implicated the common SNP rs20417 has association with PCa risk, while others showed reverse results. The study was performed with an aim to reconcile the existing controversy by performing a meta-analysis.
METHODS: We searched databases of Embase and PubMed and identified 8 publications fulfilling the specified inclusion criteria. X(2)-based Q-test and I(2) statistic were quantified to measure the heterogeneity across studies. The pooled ORs and 95% CIs were calculated to estimate the association between SNP rs20417 and PCa risk.
RESULTS: Based on an enlarged sample size by combining the data from published meta-analyses and those missed in them, the results of the present meta-analysis revealed the association of SNP rs20417 and overall PCa risk was not significant. Subgroup analyses according to ethnicity and source of controls did not show any significant results, either.
CONCLUSIONS: The meta-analysis suggests that the presence of SNP rs20417 is unlikely to be associated with PCa risk. Our understanding of the genetic risk for PCa should be further expanded and refined through future research in a much larger number of participants.

Entities:  

Keywords:  PTGS2; polymorphism; prostate cancer; rs20417

Year:  2015        PMID: 26884961      PMCID: PMC4723806     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  39 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  SNP genotyping: technologies and biomedical applications.

Authors:  Sobin Kim; Ashish Misra
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

Review 3.  Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.

Authors:  M Pairet; G Engelhardt
Journal:  Fundam Clin Pharmacol       Date:  1996       Impact factor: 2.748

4.  Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.

Authors:  Raju K Mandal; Rama D Mittal
Journal:  Arch Med Res       Date:  2011-10-21       Impact factor: 2.235

5.  Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.

Authors:  E Susan Amirian; Michael M Ittmann; Michael E Scheurer
Journal:  Prostate       Date:  2011-02-09       Impact factor: 4.104

6.  Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.

Authors:  Kim N Danforth; Richard B Hayes; Carmen Rodriguez; Kai Yu; Lori C Sakoda; Wen-Yi Huang; Bingshu E Chen; Jinbo Chen; Gerald L Andriole; Eugenia E Calle; Eric J Jacobs; Lisa W Chu; Jonine D Figueroa; Meredith Yeager; Elizabeth A Platz; Dominique S Michaud; Stephen J Chanock; Michael J Thun; Ann W Hsing
Journal:  Carcinogenesis       Date:  2007-11-13       Impact factor: 4.944

7.  Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.

Authors:  T Kosaka; A Miyata; H Ihara; S Hara; T Sugimoto; O Takeda; E Takahashi; T Tanabe
Journal:  Eur J Biochem       Date:  1994-05-01

8.  Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.

Authors:  Dong W Lee; Myung-Whun Sung; Seok-Woo Park; Weon-Jin Seong; Jong-Lyel Roh; Bumjung Park; Dae-Seog Heo; Kwang H Kim
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

Review 9.  Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.

Authors:  Raj S Pruthi; Eric Derksen; Kris Gaston
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

10.  COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.

Authors:  Xiao-feng Wang; Ming-zhu Huang; Xiao-wei Zhang; Rui-xi Hua; Wei-jian Guo
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

View more
  2 in total

1.  Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.

Authors:  Samuel B Anyona; Nicolas W Hengartner; Evans Raballah; John Michael Ong'echa; Nick Lauve; Qiuying Cheng; Paul W Fenimore; Collins Ouma; Christophe G Lambert; Benjamin H McMahon; Douglas J Perkins
Journal:  J Hum Genet       Date:  2019-10-29       Impact factor: 3.172

2.  Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.

Authors:  Yunsheng Zhang; Luogen Liu; Fang Li; Tao Wu; Hongtao Jiang; Xianxun Jiang; Xiaobo Du; Yi Wang
Journal:  Biomed Res Int       Date:  2017-06-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.